Literature DB >> 21985460

Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA.

Kyung-mi Choi1, Seung-Hye Choi, Hyesung Jeon, In-San Kim, Hyung Jun Ahn.   

Abstract

For the efficient cytoplasmic delivery of siRNA, we designed a chimeric capsid protein composed of a capsid shell, integrin targeting peptide, and p19 RNA binding protein. This recombinant protein assembled into a macromolecular container-like structure with capsid shell and provided a nanocarrier for siRNA delivery. Our capsid nanocarriers had dual affinity both for siRNA within the interior and integin receptors on the exterior, and the capsid shell structure allowed the encapsulated siRNAs to be protected from the external nucleases, leading to the enhanced stability of siRNA in serum conditions. The capsid nanocarriers could complex with siRNA in a size-dependent and sequence-independent manner and showed the pH-dependent complexing/dissocation behaviors with siRNA. Moreover, RGD peptides on the exterior surface of the capsid shell enabled the capsid nanocarriers to deliver siRNA into the cytosol of the target cells. Here, we demonstrated the superior efficiency of our siRNA/capsid nanocarrier complexes in RFP gene silencing, compared to untreated cells. These results provide an alternative approach to enhancing the stability of siRNA as well as to achieving targeted siRNA delivery.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21985460     DOI: 10.1021/nn202597c

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  20 in total

1.  Expression, purification, crystallization and preliminary crystallographic analysis of hepatitis B virus core protein dimerized via a peptide linker containing an EGFP insertion.

Authors:  Masaki Kikuchi; Shinichiro Iwabuchi; Tatsuhiko Kikkou; Keiichi Noguchi; Masafumi Odaka; Masafumi Yohda; Masaaki Kawata; Chikara Sato; Osamu Matsumoto
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-07-27

2.  IRAM: virus capsid database and analysis resource.

Authors:  Iman Almansour; Mazen Alhagri; Rahaf Alfares; Manal Alshehri; Razan Bakhashwain; Ahmed Maarouf
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

3.  Expression, purification, crystallization and preliminary X-ray crystallographic studies of hepatitis B virus core fusion protein corresponding to octahedral particles.

Authors:  Masaki Kikuchi; Shinichiro Iwabuchi; Tatsuhiko Kikkou; Keiichi Noguchi; Masafumi Odaka; Masafumi Yohda; Masaaki Kawata; Chikara Sato; Osamu Matsumoto
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-01-31

Review 4.  Safety of Nanoparticles in Medicine.

Authors:  Joy Wolfram; Motao Zhu; Yong Yang; Jianliang Shen; Emanuela Gentile; Donatella Paolino; Massimo Fresta; Guangjun Nie; Chunying Chen; Haifa Shen; Mauro Ferrari; Yuliang Zhao
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

5.  Protein Nanoparticles as Multifunctional Biocatalysts and Health Assessment Sensors.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Emily Hartzell; J Vincent Price; Wilfred Chen
Journal:  Curr Opin Chem Eng       Date:  2016-09-04       Impact factor: 5.163

Review 6.  Caged protein nanoparticles for drug delivery.

Authors:  Nicholas M Molino; Szu-Wen Wang
Journal:  Curr Opin Biotechnol       Date:  2014-01-08       Impact factor: 9.740

7.  Biological Activity Of miRNA-27a Using Peptide-based Drug Delivery Systems.

Authors:  Anna-Laurence Schachner-Nedherer; Oliver Werzer; Karin Kornmueller; Ruth Prassl; Andreas Zimmer
Journal:  Int J Nanomedicine       Date:  2019-09-25

8.  Design of a multicomponent peptide-woven nanocomplex for delivery of siRNA.

Authors:  Eunsung Jun; Soyoun Kim; Jong-Ho Kim; Kiweon Cha; In-Seop So; Hye-Nam Son; Byung-Heon Lee; Kwangmeyung Kim; Ick Chan Kwon; Sang Yoon Kim; In-San Kim
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

9.  Brain-targeted delivery of trans-activating transcriptor-conjugated magnetic PLGA/lipid nanoparticles.

Authors:  Xiangru Wen; Kai Wang; Ziming Zhao; Yifang Zhang; Tingting Sun; Fang Zhang; Jian Wu; Yanyan Fu; Yang Du; Lei Zhang; Ying Sun; YongHai Liu; Kai Ma; Hongzhi Liu; Yuanjian Song
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

Review 10.  Genetically engineered nanocarriers for drug delivery.

Authors:  Pu Shi; Joshua A Gustafson; J Andrew MacKay
Journal:  Int J Nanomedicine       Date:  2014-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.